TL;DR
Microsoft launches reasoning model at Build, alongside seven new AIs, as Anthropic debuts Sonnet 5 with lower costs and enhanced agentic features.
Microsoft’s Build conference unveiled seven new AI models, including its first reasoning model, signaling a strategic pivot toward specialized capabilities. The release aligns with industry trends where companies prioritize efficiency and targeted performance over general-purpose models. Among the new offerings, Anthropic’s Sonnet 5 stood out as a cost-effective alternative to its pricier Opus series. Priced at $2 per million input tokens initially, Sonnet 5 matches Opus 4.8’s performance while offering lower costs, making it accessible for broader adoption. Its agentic features, such as autonomous tool use and planning, position it as a competitor in the growing agentic AI market.
Anthropic’s Sonnet 5 leverages advancements in reasoning to handle complex tasks without requiring larger models. This aligns with the industry’s focus on agentic AI, where models operate independently to execute workflows. The model’s release coincides with a broader trend of AI labs optimizing for cost and specificity, as seen in Google’s Nano Banana 2 Lite and Sakana’s Fugu Ultra. These models cater to niche applications, from image generation to open-source research tools, reflecting a shift away from monolithic, high-cost systems.
The announcement also highlighted Anthropic’s Claude Science, a dedicated AI tool for researchers. Launched in beta, Claude Science integrates over 60 scientific databases and tools for tasks like 3D protein structure analysis and genomics. This product underscores AI’s expanding role in medicine and life sciences, addressing demands for specialized workflows. Researchers like Stephen Francis at UCSF have already used it to accelerate genomic studies, completing analyses in a fraction of the time. The tool’s availability on macOS and Linux for paid users suggests a push to embed AI into academic and industrial research pipelines.
While Microsoft’s reasoning model details remain sparse, its inclusion in Build’s lineup indicates a focus on practical applications. Reasoning models differ from traditional large language models by emphasizing logical deduction and problem-solving. This could impact fields like software engineering or scientific research, where step-by-step logic is critical. However, the model’s exact capabilities and benchmarks were not disclosed, leaving room for skepticism about its real-world performance compared to competitors.
The releases reflect a competitive landscape where companies balance innovation with cost. Sonnet 5’s pricing strategy and Claude Science’s research focus demonstrate how AI labs are tailoring products to specific markets. For enterprises, this means choosing between general-purpose models and specialized tools based on use cases. The emphasis on agentic capabilities also hints at future AI systems that act autonomously, reducing human intervention in complex tasks.
Despite the excitement, limitations persist. Sonnet 5’s cost increase in September and the lack of detailed benchmarks for Microsoft’s model raise questions about long-term value. Additionally, the reliance on proprietary tools and databases in products like Claude Science may create vendor lock-in risks. As the AI industry matures, transparency around model performance and ethical considerations will become critical.
The Build announcements underscore AI’s rapid evolution. From reasoning models to research-specific tools, the focus is on practicality and efficiency. However, the success of these releases will depend on real-world adoption and whether they can deliver on their promises without compromising on quality or accessibility.
About the Author
Guilherme A.
Former dentist (MD) from Brazil, 41 years old, husband, and AI enthusiast. In 2020, he transitioned from a decade-long career in dentistry to pursue his passion for technology, entrepreneurship, and helping others grow.
Connect on LinkedIn